Wall Street Experts
ver. ZuMIgo(08/25)
Sangamo Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 52
EBIT TTM (mln): -133
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
Rok finansowy |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
2 |
3 |
5 |
4 |
3 |
1 |
2 |
8 |
9 |
16 |
22 |
21 |
10 |
22 |
24 |
46 |
40 |
19 |
37 |
84 |
102 |
118 |
111 |
111 |
176 |
58 |
Przychód Δ r/r |
0.0% |
56.0% |
42.3% |
-11.1% |
-40.6% |
-49.0% |
88.9% |
217.4% |
15.4% |
77.9% |
37.1% |
-6.2% |
-50.4% |
109.9% |
11.4% |
90.1% |
-13.8% |
-51.0% |
88.6% |
131.0% |
21.3% |
15.4% |
-6.3% |
0.5% |
58.3% |
-67.2% |
Marża brutto |
131.8% |
252.4% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
-42.5% |
-52.8% |
91.5% |
89.1% |
87.4% |
100.0% |
EBIT (mln) |
-4 |
-12 |
-28 |
-32 |
-12 |
-15 |
-14 |
-21 |
-25 |
-25 |
-19 |
-25 |
-36 |
-22 |
-27 |
-27 |
-47 |
-73 |
-56 |
-77 |
-105 |
-130 |
-183 |
-201 |
-114 |
-104 |
EBIT Δ r/r |
0.0% |
220.1% |
127.8% |
11.0% |
-62.7% |
24.5% |
-6.2% |
50.8% |
19.5% |
2.4% |
-23.5% |
28.5% |
43.7% |
-38.0% |
20.3% |
0.3% |
75.0% |
54.9% |
-22.3% |
36.9% |
36.3% |
23.2% |
41.5% |
9.8% |
-43.2% |
-9.0% |
EBIT (%) |
-177.3% |
-363.6% |
-582.2% |
-726.8% |
-456.3% |
-1114.1% |
-553.5% |
-262.9% |
-272.3% |
-156.8% |
-87.4% |
-119.9% |
-347.1% |
-102.5% |
-110.7% |
-58.4% |
-118.5% |
-374.2% |
-154.1% |
-91.4% |
-102.7% |
-109.6% |
-165.6% |
-180.8% |
-64.9% |
-179.9% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-9 |
0 |
0 |
EBITDA (mln) |
-3 |
-7 |
2 |
-11 |
-10 |
-13 |
-13 |
-21 |
-25 |
-24 |
-19 |
-25 |
-36 |
-22 |
-27 |
-26 |
-47 |
-73 |
-56 |
-77 |
-105 |
-130 |
-183 |
-201 |
-92 |
-89 |
EBITDA(%) |
-145.5% |
-211.2% |
40.8% |
-247.2% |
-372.8% |
-1017.6% |
-505.8% |
-268.6% |
-273.1% |
-146.4% |
-86.1% |
-119.9% |
-347.1% |
-102.5% |
-110.2% |
-57.4% |
-118.5% |
-374.2% |
-154.1% |
-91.4% |
-102.7% |
-109.6% |
-165.6% |
-180.8% |
-52.3% |
-154.1% |
Podatek (mln) |
-0 |
-3 |
10 |
-1 |
-1 |
-1 |
-0 |
-2 |
-1 |
-1 |
-1 |
-1 |
-1 |
-1 |
-1 |
-1 |
-6 |
-0 |
-1 |
8 |
-20 |
0 |
0 |
0 |
-5 |
-0 |
Zysk Netto (mln) |
-4 |
-9 |
-25 |
-30 |
-10 |
-14 |
-13 |
-18 |
-21 |
-24 |
-19 |
-25 |
-36 |
-22 |
-27 |
-26 |
-41 |
-72 |
-55 |
-68 |
-76 |
-121 |
-178 |
-192 |
-258 |
-98 |
Zysk netto Δ r/r |
0.0% |
138.6% |
178.5% |
17.9% |
-64.9% |
32.4% |
-3.8% |
34.4% |
20.2% |
13.1% |
-23.5% |
33.7% |
43.8% |
-37.7% |
19.6% |
-0.8% |
54.1% |
76.1% |
-23.8% |
25.2% |
11.0% |
59.8% |
47.2% |
7.8% |
34.1% |
-62.0% |
Zysk netto (%) |
-172.7% |
-264.1% |
-516.9% |
-685.3% |
-404.5% |
-1050.8% |
-535.1% |
-226.6% |
-236.1% |
-150.1% |
-83.8% |
-119.5% |
-346.4% |
-102.8% |
-110.3% |
-57.6% |
-102.9% |
-369.6% |
-149.2% |
-80.9% |
-74.0% |
-102.5% |
-161.1% |
-172.8% |
-146.3% |
-169.4% |
EPS |
-0.63 |
-0.52 |
-1.09 |
-1.22 |
-0.42 |
-0.55 |
-0.51 |
-0.55 |
-0.58 |
-0.6 |
-0.44 |
-0.55 |
-0.71 |
-0.42 |
-0.48 |
-0.39 |
-0.58 |
-1.02 |
-0.7 |
-0.7 |
-0.68 |
-0.9 |
-1.23 |
-1.25 |
-1.48 |
-0.49 |
EPS (rozwodnione) |
-0.63 |
-0.52 |
-1.09 |
-1.22 |
-0.42 |
-0.55 |
-0.51 |
-0.55 |
-0.58 |
-0.6 |
-0.44 |
-0.55 |
-0.71 |
-0.42 |
-0.48 |
-0.39 |
-0.58 |
-1.02 |
-0.7 |
-0.7 |
-0.68 |
-0.9 |
-1.23 |
-1.25 |
-1.48 |
-0.49 |
Ilośc akcji (mln) |
6 |
17 |
23 |
24 |
25 |
25 |
26 |
33 |
37 |
41 |
42 |
45 |
51 |
53 |
56 |
67 |
70 |
71 |
78 |
97 |
112 |
134 |
145 |
154 |
174 |
202 |
Ważona ilośc akcji (mln) |
6 |
17 |
23 |
24 |
25 |
25 |
26 |
33 |
37 |
41 |
42 |
45 |
51 |
53 |
56 |
67 |
70 |
71 |
78 |
97 |
112 |
134 |
145 |
154 |
174 |
202 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |